These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


471 related items for PubMed ID: 22935826

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Salivary gland-like breast carcinomas: An infrequent disease.
    Sherwell-Cabello S, Maffuz-Aziz A, Ríos-Luna NP, Bautista-Piña V, Rodríguez-Cuevas S.
    Pathol Res Pract; 2016 Nov; 212(11):1034-1038. PubMed ID: 27667558
    [Abstract] [Full Text] [Related]

  • 5. [Diagnosis value of TTF-1, Napsin A and Ki-67 index in primary salivary gland-type lung carcinomas].
    Zhang B, Lin J, Da J.
    Zhonghua Bing Li Xue Za Zhi; 2015 Jul; 44(7):499-503. PubMed ID: 26705042
    [Abstract] [Full Text] [Related]

  • 6. Mammaglobin and S-100 immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma.
    Patel KR, Solomon IH, El-Mofty SK, Lewis JS, Chernock RD.
    Hum Pathol; 2013 Nov; 44(11):2501-8. PubMed ID: 24029710
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Salivary gland-type tumors of the breast: a spectrum of benign and malignant tumors including "triple negative carcinomas" of low malignant potential.
    Foschini MP, Krausz T.
    Semin Diagn Pathol; 2010 Feb; 27(1):77-90. PubMed ID: 20306833
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The morphological spectrum of salivary gland type tumours of the breast.
    Foschini MP, Morandi L, Asioli S, Giove G, Corradini AG, Eusebi V.
    Pathology; 2017 Feb; 49(2):215-227. PubMed ID: 28043647
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Polymorphous low grade adenocarcinoma has a consistent p63+/p40- immunophenotype that helps distinguish it from adenoid cystic carcinoma and cellular pleomorphic adenoma.
    Rooper L, Sharma R, Bishop JA.
    Head Neck Pathol; 2015 Mar; 9(1):79-84. PubMed ID: 24969705
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.